Evan J.C. Lee

929 total citations
27 papers, 634 citations indexed

About

Evan J.C. Lee is a scholar working on Nephrology, Cardiology and Cardiovascular Medicine and Epidemiology. According to data from OpenAlex, Evan J.C. Lee has authored 27 papers receiving a total of 634 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Nephrology, 6 papers in Cardiology and Cardiovascular Medicine and 5 papers in Epidemiology. Recurrent topics in Evan J.C. Lee's work include Dialysis and Renal Disease Management (15 papers), Chronic Kidney Disease and Diabetes (9 papers) and Renal Diseases and Glomerulopathies (5 papers). Evan J.C. Lee is often cited by papers focused on Dialysis and Renal Disease Management (15 papers), Chronic Kidney Disease and Diabetes (9 papers) and Renal Diseases and Glomerulopathies (5 papers). Evan J.C. Lee collaborates with scholars based in Singapore, United Kingdom and South Korea. Evan J.C. Lee's co-authors include Boon Wee Teo, Sunil Sethi, Jialiang Li, Huiyan Xu, Arvind Sinha, Borys Shuter, Danhua Wang, Wai-Choong Lye, Claude J. Renaud and Paul Anantharajah Tambyah and has published in prestigious journals such as Kidney International, Clinical Chemistry and American Journal of Kidney Diseases.

In The Last Decade

Evan J.C. Lee

27 papers receiving 619 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Evan J.C. Lee Singapore 13 367 132 126 115 100 27 634
Wu‐Chang Yang Taiwan 15 351 1.0× 95 0.7× 81 0.6× 114 1.0× 69 0.7× 31 726
Kwok-Yi Chung Hong Kong 14 505 1.4× 76 0.6× 157 1.2× 113 1.0× 71 0.7× 18 749
Giuseppe Quintaliani Italy 15 567 1.5× 53 0.4× 194 1.5× 96 0.8× 171 1.7× 54 851
Leslie P. Wong United States 12 355 1.0× 71 0.5× 115 0.9× 80 0.7× 54 0.5× 25 562
Emily See Australia 15 657 1.8× 123 0.9× 144 1.1× 131 1.1× 89 0.9× 68 1.0k
Mihály Tapolyai United States 14 472 1.3× 70 0.5× 89 0.7× 113 1.0× 85 0.8× 48 663
Mick Kumwenda United Kingdom 12 398 1.1× 40 0.3× 204 1.6× 191 1.7× 87 0.9× 33 665
Jeffrey L. Hymes United States 10 385 1.0× 71 0.5× 64 0.5× 107 0.9× 119 1.2× 46 677
F. T. J. Boereboom Netherlands 16 241 0.7× 88 0.7× 220 1.7× 201 1.7× 83 0.8× 25 725
Julia Lewis United States 11 614 1.7× 82 0.6× 131 1.0× 130 1.1× 208 2.1× 13 913

Countries citing papers authored by Evan J.C. Lee

Since Specialization
Citations

This map shows the geographic impact of Evan J.C. Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Evan J.C. Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Evan J.C. Lee more than expected).

Fields of papers citing papers by Evan J.C. Lee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Evan J.C. Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Evan J.C. Lee. The network helps show where Evan J.C. Lee may publish in the future.

Co-authorship network of co-authors of Evan J.C. Lee

This figure shows the co-authorship network connecting the top 25 collaborators of Evan J.C. Lee. A scholar is included among the top collaborators of Evan J.C. Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Evan J.C. Lee. Evan J.C. Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Woo, Keng-Thye, Cynthia Lim, Jason Choo, et al.. (2019). Changes in primary glomerulonephritis in Singapore over four decades. Clinical Nephrology. 91(3). 155–161. 4 indexed citations
2.
Teo, Boon Wee, Luxia Zhang, Sydney Tang, et al.. (2018). Glomerular Filtration Rates in Asians. Advances in Chronic Kidney Disease. 25(1). 41–48. 41 indexed citations
3.
Teo, Boon Wee, Weng Kin Wong, Peh Joo Ho, et al.. (2015). Spot Urine Estimations Are Equivalent to 24-Hour Urine Assessments of Urine Protein Excretion for Predicting Clinical Outcomes. International Journal of Nephrology. 2015. 1–8. 18 indexed citations
4.
Teo, Boon Wee, et al.. (2014). Comparison of Different Measures of Fat Mass and Their Association with Serum Cystatin C Levels. 2014. 1–6. 1 indexed citations
5.
Teo, Boon Wee, Huiyan Xu, Jialiang Li, et al.. (2013). Glomerular filtration rates in healthy Asians without kidney disease. Nephrology. 19(2). 72–79. 10 indexed citations
6.
Teo, Boon Wee, et al.. (2013). Spot Urine Tests in Predicting 24-Hour Urine Sodium Excretion in Asian Patients. Journal of Renal Nutrition. 23(6). 450–455. 10 indexed citations
7.
Renaud, Claude J., et al.. (2012). Comparative outcomes of primary autogenous fistulas in elderly, multiethnic Asian hemodialysis patients. Journal of Vascular Surgery. 56(2). 433–439. 32 indexed citations
8.
Teo, Boon Wee, Huiyan Xu, Danhua Wang, et al.. (2011). GFR Estimating Equations in a Multiethnic Asian Population. American Journal of Kidney Diseases. 58(1). 56–63. 217 indexed citations
9.
Teo, Boon Wee, et al.. (2010). Microbiology of Tunnelled Catheter-Related Infections in a Multi-Ethnic South-East Asian Patient Population. Nephron Clinical Practice. 118(2). c86–c92. 5 indexed citations
11.
Tsukamoto, Yusuke, Haiyan Wang, Gavin J. Becker, et al.. (2009). Report of the Asian Forum of Chronic Kidney Disease Initiative (AFCKDI) 2007. “Current status and perspective of CKD in Asia”: diversity and specificity among Asian countries. Clinical and Experimental Nephrology. 13(3). 249–256. 26 indexed citations
12.
Woo, Keng-Thye, Marjorie Foo, Evan J.C. Lee, et al.. (2008). High dose Losartan and ACE gene polymorphism in IgA nephritis. PubMed. 2(3-4). 83–91. 7 indexed citations
13.
Wong, Kok‐Seng, et al.. (2005). Health economics of renal replacement therapy: Perspectives from Singapore. Kidney International. 67(94). S19–S22. 26 indexed citations
14.
Lee, Evan J.C., et al.. (2001). Serum ascorbic acid and protein calorie malnutrition in continuous ambulatory peritoneal dialysis patients.. National University of Singapore. 17. 219–22. 11 indexed citations
15.
Lim, Su Lin, et al.. (2001). Oral intake and serum levels of ascorbic acid in continuous ambulatory peritoneal dialysis patients.. PubMed. 17. 215–8. 15 indexed citations
16.
Lye, Wai-Choong, et al.. (1999). Once-Daily Intraperitoneal Gentamicin is Effective Therapy for Gram-Negative Capd Peritonitis. Peritoneal Dialysis International. 19(4). 357–360. 17 indexed citations
17.
Lye, Wai-Choong, et al.. (1996). Transplant Renal Artery Stenosis Presenting with Recurrent Acute Pulmonary Edema. ˜The œNephron journals/Nephron journals. 72(2). 302–304. 11 indexed citations
18.
Lye, Wai-Choong, et al.. (1995). Acute cyclosporine a nephrotoxicity in a renal allograft recipient with hypothyroidism. American Journal of Kidney Diseases. 25(3). 503–505. 10 indexed citations
19.
Lee, Evan J.C., et al.. (1994). Clinical Characteristics and Outcome of Acinetobacter Infections in Capd Patients. Peritoneal Dialysis International. 14(2). 174–176. 12 indexed citations
20.
Lye, Wai-Choong, et al.. (1993). Intraperitoneal Vancomycin/Oral Pefloxacin versus Intraperitoneal Vancomycin/Gentamicin in the Treatment of Continuous Ambulatory Peritoneal Dialysis Peritonitis. Peritoneal Dialysis International. 13(2_suppl). 348–350. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026